Logo Passei Direto
Buscar
Material
páginas com resultados encontrados.
páginas com resultados encontrados.

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Escolha uma das opções e acesse esse e outros materiais sem bloqueio. 🤩

Cadastre-se ou realize login

Ao continuar, você aceita os Termos de Uso e Política de Privacidade

Prévia do material em texto

Report
Cellular Phenotypes in Hu
man iPSC-Derived
Neurons from a Genetic Model of Autism Spectrum
Disorder
Graphical Abstract
Highlights
d Cellular model of NDDs established using hiPSCs from
16pdel and 16pdup carriers
d Opposing neuronal size phenotype may model macro- and
microcephaly
d Synaptic impairment in 16pdel and 16pdup neurons may
reflect behavioral features
d Functional compensation observed in 16pdup compared
with 16pdel neurons
Deshpande et al., 2017, Cell Reports 21, 2678–2687
December 5, 2017 ª 2017 The Authors.
https://doi.org/10.1016/j.celrep.2017.11.037
Authors
Aditi Deshpande, Smita Yadav,
Dang Q. Dao, ..., Yuh-Nung Jan,
Erik M. Ullian, Lauren A. Weiss
Correspondence
lauren.weiss@ucsf.edu
In Brief
Deshpande et al. show that neurons
derived from individuals harboring
neurodevelopmental disorders caused by
the 16p11.2 deletion or duplication
manifest contrasting cellular phenotypes
that may underlie the macro- or
microcephaly observed in carriers,
respectively. Comparable functional
changes in deletion- and duplication-
derived neurons suggest similar
mechanisms underlying common clinical
features, like autism.
mailto:lauren.weiss@ucsf.edu
https://doi.org/10.1016/j.celrep.2017.11.037
http://crossmark.crossref.org/dialog/?doi=10.1016/j.celrep.2017.11.037&domain=pdf
Cell Reports
Report
Cellular Phenotypes in Human iPSC-Derived Neurons
from a Genetic Model of Autism Spectrum Disorder
Aditi Deshpande,1,2,3 Smita Yadav,4,5,6 Dang Q. Dao,7 Zhi-Yong Wu,1,2,3 Kenton C. Hokanson,7,8 Michelle K. Cahill,8
Arun P. Wiita,9 Yuh-Nung Jan,4,5,6 Erik M. Ullian,7,8 and Lauren A. Weiss1,2,3,10,*
1Department of Psychiatry, University of California, San Francisco, San Francisco, CA, 94143, USA
2Institute for Human Genetics, University of California, San Francisco, San Francisco, CA, 94143, USA
3Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA
4Howard Hughes Medical Institute
5Department of Physiology
6Department of Biochemistry and Biophysics
University of California, San Francisco, San Francisco, CA 94158, USA
7Department of Ophthalmology, University of California, San Francisco, CA 94143, USA
8Neuroscience Graduate Program, University of California, San Francisco, CA 94158, USA
9Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94107, USA
10Lead Contact
*Correspondence: lauren.weiss@ucsf.edu
https://doi.org/10.1016/j.celrep.2017.11.037
SUMMARY
A deletion or duplication in the 16p11.2 region
is associated with neurodevelopmental disorders,
including autism spectrum disorder and schizo-
phrenia. In addition to clinical characteristics, car-
riers of the 16p11.2 copy-number variant (CNV) man-
ifest opposing neuroanatomical phenotypes—e.g.,
macrocephaly in deletion carriers (16pdel) and
microcephaly in duplication carriers (16pdup). Using
fibroblasts obtained from 16pdel and 16pdup car-
riers, we generated induced pluripotent stem cells
(iPSCs) and differentiated them into neurons to iden-
tify causal cellular mechanisms underlying neurobio-
logical phenotypes. Our study revealed increased
soma size and dendrite length in 16pdel neurons
and reduced neuronal size and dendrite length in
16pdup neurons. The functional properties of iPSC-
derived neurons corroborated aspects of these con-
trasting morphological differences that may underlie
brain size. Interestingly, both 16pdel and 16pdup
neurons displayed reduced synaptic density, sug-
gesting that distinct mechanisms may underlie brain
size and neuronal connectivity at this locus.
INTRODUCTION
The increasing prevalence of autism spectrum disorder (ASD)
highlights the importance of identifying biomarkers and thera-
peutic targets. This complex neurodevelopmental disorder
(NDD) is characterized by repetitive or stereotypic behaviors as
well as communication and social deficits (American Psychiatric
Association, 2013). However, the neurobiological mechanisms
underlying the pathology of ASD are not well understood.
Of the known genetic etiologies for ASD, rare and recurrent
2678 Cell Reports 21, 2678–2687, December 5, 2017 ª 2017 The Au
This is an open access article under the CC BY license (http://creative
copy-number variants (CNVs) have emerged as highly penetrant
risk factors (Malhotra and Sebat, 2012). The 16p11.2 CNV is an
�600-kb locus harboring 29 annotated genes, most of which
are highly expressed in the brain; deletion or duplication of this
locus is associated with ASD (Weiss et al., 2008). The levels of
mRNA expression of 16p11.2 genes correspond to copy number
in human lymphoblastoid cell lines (LCLs), in induced pluripotent
stem cells (iPSCs), and in the mouse brain; i.e., reduced in dele-
tion carriers (16pdel) and increased in duplication carriers
(16pdup) (Blumenthal et al., 2014; Tai et al., 2016). Studies in an-
imal models and transcriptome analyses in LCLs have identified
genes in the region involved in synaptogenesis, chromatin
modulation, and ciliary function (Blumenthal et al., 2014; Luo
et al., 2012; Migliavacca et al., 2015). In addition to ASD, the
16p11.2 deletion is a risk factor for developmental delay (DD),
language impairment, and epilepsy, whereas the reciprocal
duplication predisposes carriers to schizophrenia, bipolar disor-
der, DD, and seizures (Kumar et al., 2008; McCarthy et al., 2009;
Rosenfeld et al., 2010; Shinawi et al., 2010; Weiss et al.,
2008). Despite common behavioral symptoms, including ASD,
16p11.2 CNV carriers manifest opposing neuroanatomical phe-
notypes, such as macrocephaly in 16pdel and microcephaly in
16pdup (Qureshi et al., 2014).
Interestingly, head circumference or brain size changes occur
in additional genetic etiologies of ASD and NDDs. For example,
loss-of-function mutations in the PTEN gene have been shown
to result in extreme macrocephaly and ASD (Butler et al.,
2005). Disruptive mutations in CHD8 are associated with ASD
and macrocephaly (Bernier et al., 2014). Other CNVs, such as
the 1q21.1 duplication, predispose to ASD and macrocephaly
in addition to intellectual disability (ID) and schizophrenia (Mef-
ford et al., 2008; Milone et al., 2016). In contrast, microcephaly is
observed in carriers with mutations inDYRK1A along with a pre-
disposition for ID, ASD, and seizures (Ji et al., 2015). Although
both macrocephaly and microcephaly can be associated with
ASD, studies demonstrating that the same gene (or pathway)
can cause both macrocephaly and microcephaly (e.g., via
thors.
commons.org/licenses/by/4.0/).
mailto:lauren.weiss@ucsf.edu
https://doi.org/10.1016/j.celrep.2017.11.037
http://crossmark.crossref.org/dialog/?doi=10.1016/j.celrep.2017.11.037&domain=pdf
http://creativecommons.org/licenses/by/4.0/
gain- or loss-of-function mutations) are lacking. Thus, the
16p11.2 CNV appears to be uniquely poised to investigate
whether a single cellular mechanism, dysregulated in opposite
directions, could be responsible for opposing brain size pheno-
types. Furthermore, the relationship between brain growth
mechanisms and ASD-relevant functional characteristics could
be applicable to a range of ASD risk factors.
At the cellular level, brain overgrowth or undergrowth often
result from dysregulation of early developmental pathways in
neural progenitor cells (NPCs). The cellular processes that can
be disrupted are cell proliferation and apoptosis, cell growth,
or differentiation (Groszer et al., 2001; Homem et al., 2015). We
hypothesize that perturbation of one or more of these cellular
processes may underlie the brain growth phenotype in 16p11.2
CNV carriers, given that the CNV harbors genes known to
manifest early neurobiological phenotypes when dysregulated.
Noteworthy examples are MAPK3, a key component of the
Ras/mitogen-activated protein kinase (MAPK) pathway which
regulates multiple processes, including proliferation and differ-
entiation; TAOK2, a kinase essential for dendrite and spine
morphogenesis;and KCTD13, a ubiquitin ligase family member
shown to affect head size by altering NPC proliferation and
apoptosis in a dose-dependent manner in zebrafish (de Anda
et al., 2012; Golzio and Katsanis, 2013; Pucilowska et al.,
2015; Yadav et al., 2017). However, the cellular mechanisms in
16p11.2 CNV carriers underlyingmacro- or microcephaly remain
unknown. Further, it is unclear whether behavioral symptoms
common to these CNVs are a direct consequence of the same
mechanism underlying differences in brain size.
To test whether early developmental processes underlie the
brain size phenotype, we generated iPSCs from fibroblasts of
16pdel and 16pdup carriers and controls. We differentiated
them into forebrain cortical neurons. We assessed proliferation
by examining cell cycle markers, cell growth by measuring
soma size, and differentiation by measuring dendritic growth
and synaptic development. Finally, we assessed the electro-
physiological properties of iPSC-derived neurons to determine
whether they reflect the observed morphological differences
and assessed synaptic development to determine whether the
same mechanism contributing to brain size may also influence
functional properties.
RESULTS
Generation of iPSCs from 16p11.2 CNV Carriers and
Differentiation into NPCs
The 16p11.2 CNV carrier-derived iPSCs were comparable with
control iPSCs with respect to stem cell marker expression and
pluripotency (Figures 1Aand1B; FiguresS1Aand1B). To confirm
that iPSCs retained the CNV status after reprogramming, we
assessed, by qRT-PCR, the mRNA levels of selected genes
spanning the 16p11.2 CNV. We found that generally the expres-
sion of QPRT, MVP, KCTD13, TAOK2, ALDOA, TBX6, MAPK3,
and CORO1A was decreased to about 0.3–0.5 times in 16pdel
lines and increased by about 1.2–1.5 times in 16pdup lines
when normalized to controls (Figure 1C; Figure S1C).
We then differentiated iPSCs to forebrain cortical neurons
(Zhang et al., 2001; Figure 1D). We generated NPCs from three
carriers each of 16pdel and 16pdup and four controls and
analyzed 2–3 clones per individual for each experiment
described (Table S4). The proportion of specific forebrain NPC
markers, such as PAX6 and nestin, in 16pdel, control, and
16pdup was comparable, suggesting induction of dorsal fore-
brain identity (Figures 1E and 1F; Figures S2C and S2D). Quan-
titative RT-PCR for selected 16p11.2 genes in NPCs generally
showed the expected expression patterns; i.e., decreased in
16pdel and increased in 16pdup (Figure S2A). We then checked
NPC proliferation by 5-ethynyl-20-deoxyuridine (EdU) incorpora-
tion assay; the proportion of EdU+ NPCs was not significantly
different in either 16pdel or 16pdup NPCs compared with con-
trols after a 24-hr chase following a 4-hr EdU pulse (p = 0.56
and 1.0, respectively; Figures 1E and 1G). To assess whether
the self-renewal capacity of NPCs was altered, we incubated
NPCs with EdU, followed 24 hr and 48 hr later with a 1-hr pulse
of bromodeoxyuridine (BrdU). We did not observe a statistically
significant difference in EdU-only (cells that exited the cell cycle)
in the 24-hr (16pdel, p = 0.53; 16pdup, p = 0.79) or 48-hr (16pdel,
p = 0.19; 16pdup, p = 1.0) paradigm. The proportion of EdU+/
BrdU+ double-labeled cells (that reentered the cell cycle) was
also not significantly altered between 16pdel, control, and
16pdup NPCs at 24 hr (16pdel, p = 0.29; 16pdup, p = 0.25) or
48 hr (16pdel, p = 0.56; 16pdup, p = 0.56; Figures S2B and
S2E–S2J). Because the proliferation rate of 16pdel and 16pdup
NPCs was unchanged compared with controls, it is unlikely to
account for the opposing brain size phenotype in human carriers.
16p11.2 CNV Carrier-Derived Neurons Show Altered
Morphometric Characteristics
Wenext investigatedwhether neuronmorphologymay contribute
to brain size.We plated the 16pdel, control, and 16pdupNPCs for
differentiation into neurons about 4 weeks after neural induction.
For visualization, we transduced the cultures with a lentivirus
expressing GFP under the neuron-specific synapsin promoter
(SynGFP). 3 weeks post-differentiation (wpd), the 16pdel
SynGFP+ neurons showed neuronal hypertrophy compared
with controls, whereas the soma size of 16pdup neurons was
reduced (16pdel, p = 3.39 3 10�5; 16pdup, p = 4.1 3 10�4;
Figures S3A and S3B). At 6 wpd, the soma size of 16pdel neurons
was significantly larger (p = 7.723 10�6), whereas that of 16pdup
neurons was significantly smaller (p = 6.11 3 10�12) compared
with control neurons (Figures 2A and 2B). This prompted us to
assess whether the change in neuronal size is restricted to the
soma or is also reflected in other morphological features. Our an-
alyses revealed that 16pdel neurons have increased total
dendrite length (p = 4.523 10�5) andmore extensive dendritic ar-
bors (pneurons was not significantly decreased (p =
0.38; Figures S3C–S3F). The opposing soma size phenotype
was robustly maintained through 14 wpd (Figure 2E). qRT-PCR
for selected 16p11.2 genes in 6-wpd neurons also generally
correlated with copy number; i.e., decreased in 16pdel carriers
and increased in 16pdup carriers (Figure S4A). Thus, neurons
generated from 16pdel- and 16pdup-derived NPCs, specifically
excitatory neurons, manifest overt and opposing differences in
soma size and total dendrite length that may contribute to head
circumference phenotypes observed in carriers.
Intrinsic Excitability of 16pdel Carrier-Derived Neurons
Corroborates the Cell Size Phenotype
The intrinsic properties of neurons can be affected by cell size
and morphology. Our results showing altered soma size associ-
ated with 16p11.2 CNV led us to examine whether this translates
to altered electrical properties and, eventually, neuron function.
We performed patch-clamp electrophysiology at 14 wpd on
SynGFP+ 16pdel, control, and 16pdup neurons. We examined
the ability of the 16p11.2 CNV carrier-derived neurons to fire ac-
pr
Th
co
im
wh
di
tro
co
th
re
in
sig
at
p
sh
co
th
pl
po
sa
sig
Ho
(p
Cell Repo
tion potentials (APs), the bona fide physi-
ological marker of neurons. When in-
jected with current to evoke APs, 16pdel
neurons required nearly twice as much
current as control neurons to fire the first
AP (p = 2.02 3 10�3; Figures 3A and
3B), and they fired far fewer APs at any
particular current step than either of the
other two groups (pin synaptic function, we recorded
miniature excitatory postsynaptic currents (mEPSCs) in 8 to
9 wpd CaMKIIaGFP+ neurons. We did not observe a significant
difference in the kinetics (16pdel, p = 0.29; 16pdup, p = 0.88) or
frequency (16pdel, p = 0.46; 16pdup, p = 0.33) of the mEPSCs in
16pdel and 16pdup neurons compared with controls (Figures
S4F and S4H). However, the amplitude of mEPSCs was signifi-
cantly increased in both 16pdel and 16dup neurons (16pdel,
psynaptic function andmatu-
ration are warranted.
Although we observed that reduced soma size was corrobo-
rated by a trend of reduced Cm in 16pdup neurons, other intrinsic
excitability parameters, such as AP firing or Rinp, did not deviate
from controls. This suggests either a compensation for morpho-
logical changes or a subtle phenotype that would not be readily
observed in our model system. For example, the upregulation in
potassium conductance may serve to preserve a normal amount
of potassium flux, which helps preserve excitability, indicative of
compensation by 16pdup neurons for their reduced size. How-
ever, consistent with the synaptic defects in 16pdel neurons,
16pdup neurons showed a reduced synaptic density and
increased mEPSC amplitude. Thus, although 16pdup neurons
may retain the capacity to rebalance membrane conductance
to preserve excitability, they exhibit substantial deficits in synap-
tic connectivity and function.
Themore evident cellular phenotypes observed in 16pdel neu-
rons compared with 16pdup neurons may result from the more
dramatic fold change in gene expression for deletion (0.53)
compared with duplication (1.53) CNVs. Alternatively, it may
result from under-expression generally being more impactful
than overexpression because having less of a critical protein
could be more difficult to overcome than excess protein (e.g.,
when other limiting factors exist). This pattern may underlie
the failure of the hypertrophic 16pdel neurons to functionally
compensate for increased size (e.g., AP firing), resulting in strik-
ing physiological defects that affect the formation and function of
neural networks. The hypotrophic 16pdup neurons, on the other
hand, are capable of homeostatically regulating their excitability.
These findings at the cellular level are consistent with clinical fea-
tures, given that neurological symptoms, although incompletely
penetrant, aremore common among 16pdel carriers than among
16pdup carriers, who often show milder or no clinical features
(Golzio and Katsanis, 2013; Steinman et al., 2016). Moreover,
the cellular phenotypes were extremely consistent in each group
(across individuals and clones), supporting the robustness of our
conclusions despite inter-individual variation. In summary, our
iPSC-derived model of 16p11.2 CNVs provides evidence of
causal neuronal and synaptic phenotypes that might contribute
to neuropathology associated with 16p11.2 CNVs, are present
in a system amenable to manipulation, and, in future studies,
will be important in establishing a gene/pathway-phenotype
correlation.
EXPERIMENTAL PROCEDURES
16p11.2 CNV Carriers
Skin fibroblasts of three 16p11.2 deletion and three duplication carriers were
obtained from the Simons Variation in Individuals Project (VIP) and used for re-
programming to iPSCs (Simons VIP Consortium, 2012). Fibroblasts of control
individuals were obtained by punch biopsies using published protocols
(Rooney et al., 2016). The control line BJ4 was a kind gift from the Hsiao lab
(Matsumoto et al., 2013). Carrier and control lines are described in Table S1.
All human research was performed in accordance with institutional review
board (IRB) and Committee on Human Research codes of practice (IRB proto-
cols 10-03304, 10-01426, and 10-02794).
Generation of iPSCs Using Episomal Vectors
Fibroblasts were cultured in DMEM with 10% fetal bovine serum (FBS) (Life
Technologies) and reprogramed to iPSCs with the episomal plasmids
pCXLE-hOct3/4-shp53-F, pCXLE-hSox2-Klf4, and pCXLE-hcmyc-Lin28
(Addgene) using published protocols (Okita et al., 2011). Briefly, cells were
electroporated with 3 mg plasmid mixture using the Neon transfection device
(Invitrogen) according to the manufacturer’s protocol (1, 650 V, 10 ms width,
and 3 pulses). Transfected cells were plated on mitomycin C-treated mouse
embryonic fibroblasts (MEFs, Millipore) in human embryonic stem (hES)
medium: knockout DMEM/F-12, 13 knockout serum replacement, 1% non-
essential amino acids, 1% penicillin/streptomycin (Life Technologies) with
bFGF. The iPSC colonies were picked manually after 2 weeks and transferred
to MEF feeders in hES medium. After a few passages on MEFs, iPSCs were
transferred to plates coated with Matrigel (BD Biosciences) and maintained
in mTeSR-1 medium (Stem Cell Technologies). All experiments were per-
formed with 2–3 independent iPSC clones per line.
Characterization of iPSCs from 16p11.2 CNV Carriers
Induced PSCs were stained for nanog, OCT4, SOX2, and SSEA-4. For
pluripotency analysis, iPSCs were allowed to differentiate spontaneously in
mTeSR-1 medium or randomly differentiated using the Human Pluripotent
Stem Cell Functional Identification Kit (SC027, R&D Systems) and stained
for markers of the three germ layers. All iPSCs generated cells of all three
germ layers, as assessed by positive immunoreactivity for b-III-tubulin for
ectoderm, smooth muscle actin for mesoderm, and SOX17 for endoderm.
For the array comparative genomic hybridization (CGH), DNA was extracted
using the QIAamp DNA Blood Mini Kit (QIAGEN) according to the manufac-
turer’s protocol and eluted in nuclease-free water. Eluted DNA was
processed for analysis by Illumina CytoSNP 850K array according to the
manufacturer’s protocol. Data were processed, and CNV calls were generated
with BlueFuse Multi Software v4.2 (Illumina). CNV calls by SNP array were re-
ported using standard clinical thresholds in the University of California San
Francisco (UCSF) Clinical Cytogenetics Laboratory, including annotation of
any CNVs > 200 kb. Interpretation of clinical significance was done according
to standard American College of Medical Genetics guidelines (Kearney et al.,
2011). See Table S2 for array CGH results.
Statistical Analyses
All results are represented as bar or line plots using the ggplot2 library in the
R 3.2.0 environment (https://www.r-project.org). Bar plots show means ± SE
for the 16pdel, control, and 16pdup groups. Symbols represent all lines
used in the study. Statistical significance between the groups was assessed
with the Mann-Whitney-Wilcoxon signed-rank test with the wilcox.test() func-
tion in R. Line plots show means ± SE for each group for repeated measure-
ments. Statistical significance was calculated using repeated-measures
ANOVA with post hoc Tukey’s honest significant difference (HSD) correction
using the aov() and TukeyHSD() functions in R.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.11.037.
AUTHOR CONTRIBUTIONS
Conceptualization, A.D. and L.A.W; Methodology, A.D., L.A.W., S.Y., D.Q.D.,
and E.M.U.; Investigation, A.D., S.Y., D.Q.D., Z.-Y.W., K.C.H., M.K.C., and
A.P.W.; Writing – Original Draft, L.A.W. and A.D.; Writing – Review & Editing,
L.A.W., A.D., S.Y., D.Q.D., Z.-Y.W., K.C.H., E.M.U., and Y.-N.J.; Funding
Acquisition, L.A.W., E.M.U., and Y.-N.J.
ACKNOWLEDGMENTS
We thank Curtis Tom, Federico Mendoza-Camacho, Cheuk Tam, John Paul
Kwok, Tracy Hyunh, and Shriya Perati for technical assistance. We also thank
Dr. Edward Hsaio for kindly sharing the BJ4 iPSC line and Dr. Michela Traglia
for her expertise in using the R software. We thank Michael Ho of the UCSF
Clinical Cytogenetics Laboratory for processing samples for array CGH. We
are grateful to all families participating in the Simons VIP. We appreciate ac-
cess to phenotypic data on the SFARI Base. This work was supported by a
grant from the Simons Foundation (SFARI 345471 to L.A.W. and E.M.U.).
This work was funded by NIH DP2 OD007449, NIH R21 MH105745, and a
CIRM Bridges grant to CCSF (#TB1-01188) and IMHRO (to L.A.W.). A.D.
was supported by the Autism Speaks Meixner Postdoctoral Fellowship in
Translational Research (#9224). S.Y. was supported by NIH Pathway to Inde-
pendence Grant 5K99MH108648-02. D.Q.D. and K.C.H.were funded by NIH
T32 Training Grant EY007120. E.M.U. was funded by a Research to Prevent
Cell Reports 21, 2678–2687, December 5, 2017 2685
https://www.r-project.org
https://doi.org/10.1016/j.celrep.2017.11.037
Blindness Unrestricted Grant, Allen Family Foundation Distinguished Investi-
gator Award and NEI EY002162.
Received: January 12, 2017
Revised: September 1, 2017
Accepted: November 10, 2017
Published: December 5, 2017
REFERENCES
American Psychiatric Association (2013). Diagnostic and Statistical Manual of
Mental Disorders (Arlington, VA: Americal Psychiatric Publishing).
Benavides-Piccione, R., Dierssen, M., Ballesteros-Yáñez, I., Martı́nez de
Lagrán, M., Arbonés, M.L., Fotaki, V., DeFelipe, J., and Elston, G.N. (2005).
Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/-
mouse. Neurobiol. Dis. 20, 115–122.
Bernier, R., Golzio, C., Xiong, B., Stessman, H.A., Coe, B.P., Penn, O., Wither-
spoon, K., Gerdts, J., Baker, C., Vulto-van Silfhout, A.T., et al. (2014). Disrup-
tive CHD8mutations define a subtype of autism early in development. Cell 158,
263–276.
Bizzotto, S., and Francis, F. (2015). Morphological and functional aspects of
progenitors perturbed in cortical malformations. Front. Cell. Neurosci. 9, 30.
Blumenthal, I., Ragavendran, A., Erdin, S., Klei, L., Sugathan, A., Guide, J.R.,
Manavalan, P., Zhou, J.Q., Wheeler, V.C., Levin, J.Z., et al. (2014). Transcrip-
tional consequences of 16p11.2 deletion and duplication in mouse cortex and
multiplex autism families. Am. J. Hum. Genet. 94, 870–883.
Butler, M.G., Dasouki, M.J., Zhou, X.-P., Talebizadeh, Z., Brown, M., Takaha-
shi, T.N., Miles, J.H., Wang, C.H., Stratton, R., Pilarski, R., and Eng, C. (2005).
Subset of individuals with autism spectrum disorders and extreme macroce-
phaly associated with germline PTEN tumour suppressor gene mutations.
J. Med. Genet. 42, 318–321.
Costa, V., Aigner, S., Vukcevic, M., Sauter, E., Behr, K., Ebeling, M., Dunkley,
T., Friedlein, A., Zoffmann, S., Meyer, C.A., et al. (2016). mTORC1 Inhibition
Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem
Cell Model of Tuberous Sclerosis. Cell Rep. 15, 86–95.
de Anda, F.C., Rosario, A.L., Durak, O., Tran, T., Gräff, J., Meletis, K., Rei, D.,
Soda, T., Madabhushi, R., Ginty, D.D., et al. (2012). Autism spectrum disorder
susceptibility gene TAOK2 affects basal dendrite formation in the neocortex.
Nat. Neurosci. 15, 1022–1031.
Fotaki, V., Dierssen, M., Alcántara, S., Martı́nez, S., Martı́, E., Casas, C., Visa,
J., Soriano, E., Estivill, X., and Arbonés, M.L. (2002). Dyrk1A haploinsufficiency
affects viability and causes developmental delay and abnormal brain
morphology in mice. Mol. Cell. Biol. 22, 6636–6647.
Gilmore, E.C., and Walsh, C.A. (2013). Genetic causes of microcephaly and
lessons for neuronal development. Wiley Interdiscip. Rev. Dev. Biol. 2,
461–478.
Golzio, C., and Katsanis, N. (2013). Genetic architecture of reciprocal CNVs.
Curr. Opin. Genet. Dev. 23, 240–248.
Golzio, C., Willer, J., Talkowski, M.E., Oh, E.C., Taniguchi, Y., Jacquemont, S.,
Reymond, A., Sun, M., Sawa, A., Gusella, J.F., et al. (2012). KCTD13 is a major
driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number
variant. Nature 485, 363–367.
Groszer, M., Erickson, R., Scripture-Adams, D.D., Lesche, R., Trumpp, A.,
Zack, J.A., Kornblum, H.I., Liu, X., and Wu, H. (2001). Negative regulation of
neural stem/progenitor cell proliferation by the Pten tumor suppressor gene
in vivo. Science 294, 2186–2189.
Habela, C.W., Song, H., and Ming, G.-L. (2016). Modeling synaptogenesis in
schizophrenia and autism using human iPSC derived neurons. Mol. Cell. Neu-
rosci. 73, 52–62.
Homem, C.C.F., Repic, M., and Knoblich, J.A. (2015). Proliferation control in
neural stem and progenitor cells. Nat. Rev. Neurosci. 16, 647–659.
Ji, J., Lee, H., Argiropoulos, B., Dorrani, N., Mann, J., Martinez-Agosto, J.A.,
Gomez-Ospina, N., Gallant, N., Bernstein, J.A., Hudgins, L., et al. (2015).
DYRK1A haploinsufficiency causes a new recognizable syndrome with micro-
2686 Cell Reports 21, 2678–2687, December 5, 2017
cephaly, intellectual disability, speech impairment, and distinct facies. Eur. J.
Hum. Genet. 23, 1473–1481.
Kearney, H.M., Thorland, E.C., Brown, K.K., Quintero-Rivera, F., and South,
S.T.; Working Group of the American College of Medical Genetics Laboratory
Quality Assurance Committee (2011). American College of Medical Genetics
standards and guidelines for interpretation and reporting of postnatal constitu-
tional copy number variants. Genet. Med. 13, 680–685.
Kolli, S., Zito, C.I., Mossink, M.H., Wiemer, E.A.C., and Bennett, A.M. (2004).
The major vault protein is a novel substrate for the tyrosine phosphatase
SHP-2 and scaffold protein in epidermal growth factor signaling. J. Biol.
Chem. 279, 29374–29385.
Kumar, V., Zhang, M.-X., Swank, M.W., Kunz, J., and Wu, G.-Y. (2005). Regu-
lation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK
signaling pathways. J. Neurosci. 25, 11288–11299.
Kumar, R.A., KaraMohamed, S., Sudi, J., Conrad, D.F., Brune, C., Badner,
J.A., Gilliam, T.C., Nowak, N.J., Cook, E.H., Jr., Dobyns, W.B., and Christian,
S.L. (2008). Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17,
628–638.
Kwon, C.H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart,
C.G., Burger, P.C., and Baker, S.J. (2001). Pten regulates neuronal soma size:
a mouse model of Lhermitte-Duclos disease. Nat. Genet. 29, 404–411.
Luo, R., Sanders, S.J., Tian, Y., Voineagu, I., Huang, N., Chu, S.H., Klei, L., Cai,
C., Ou, J., Lowe, J.K., et al. (2012). Genome-wide transcriptome profiling re-
veals the functional impact of rare de novo and recurrent CNVs in autism spec-
trum disorders. Am. J. Hum. Genet. 91, 38–55.
Malhotra, D., and Sebat, J. (2012). CNVs: harbingers of a rare variant revolution
in psychiatric genetics. Cell 148, 1223–1241.
Matsumoto, Y., Hayashi, Y., Schlieve, C.R., Ikeya, M., Kim, H., Nguyen, T.D.,
Sami, S., Baba, S., Barruet, E., Nasu, A., et al. (2013). Induced pluripotent stem
cells from patients with human fibrodysplasia ossificans progressiva show
increased mineralization and cartilage formation. Orphanet J. Rare Dis. 8, 190.
McCarthy, S.E., Makarov, V., Kirov, G., Addington, A.M., McClellan, J., Yoon,
S., Perkins, D.O., Dickel, D.E., Kusenda, M., Krastoshevsky, O., et al.; Well-
come Trust Case Control Consortium (2009). Microduplications of 16p11.2
are associated with schizophrenia. Nat. Genet. 41, 1223–1227.
Mefford, H.C., Sharp, A.J., Baker, C., Itsara, A., Jiang, Z., Buysse, K., Huang,
S., Maloney, V.K., Crolla, J.A., Baralle, D., et al. (2008). Recurrent rearrange-
ments of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J.
Med. 359, 1685–1699.
Migliavacca, E., Golzio, C., Männik, K., Blumenthal, I., Oh, E.C., Harewood, L.,
Kosmicki, J.A., Loviglio, M.N., Giannuzzi, G., Hippolyte, L., et al.; 16p11.2 Eu-
ropean Consortium (2015). A Potential Contributory Role for Ciliary Dysfunc-
tion in the 16p11.2 600 kb BP4-BP5 Pathology. Am. J. Hum. Genet. 96,
784–796.
Milone, R., Valetto, A., Battini, R., Bertini, V., Valvo, G., Cioni, G., and Sicca, F.
(2016). Focal cortical dysplasia, microcephaly and epilepsy in a boy with
1q21.1-q21.3 duplication. Eur. J. Med. Genet. 59, 278–282.
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S.,
Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K., et al. (2011). A more efficient
method to generate integration-free human iPS cells. Nat. Methods 8,
409–412.
Pucilowska, J., Vithayathil, J., Tavares, E.J., Kelly, C., Karlo, J.C., and Land-
reth, G.E. (2015). The 16p11.2 deletion mousemodel of autism exhibits altered
cortical progenitor proliferation and brain cytoarchitecture linked to the ERK
MAPK pathway. J. Neurosci. 35, 3190–3200.
Qureshi, A.Y., Mueller, S., Snyder, A.Z., Mukherjee, P., Berman, J.I., Roberts,
T.P.L.,Nagarajan, S.S., Spiro, J.E., Chung, W.K., Sherr, E.H., and Buckner,
R.L.; Simons VIP Consortium (2014). Opposing brain differences in 16p11.2
deletion and duplication carriers. J. Neurosci. 34, 11199–11211.
Rauen, K.A. (2013). The RASopathies. Annu. Rev. Genomics Hum. Genet. 14,
355–369.
Rooney, G.E., Goodwin, A.F., Depeille, P., Sharir, A., Schofield, C.M., Yeh, E.,
Roose, J.P., Klein, O.D., Rauen, K.A., Weiss, L.A., and Ullian, E.M. (2016).
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref1
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref1
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref2
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref2
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref2
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref2
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref3
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref3
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref3
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref3
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref4
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref4
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref5
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref5
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref5
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref5
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref6
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref6
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref6
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref6
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref6
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref7
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref7
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref7
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref7
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref8
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref8
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref8
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref8
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref9
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref9
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref9
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref9
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref10
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref10
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref10
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref11
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref11
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref12
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref12
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref12
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref12
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref13
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref13
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref13
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref13
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref14
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref14
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref14
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref15
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref15
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref16
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref16
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref16
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref16
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref16
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref17
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref17
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref17
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref17
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref17
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref18
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref18
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref18
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref18
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref19
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref19
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref19
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref20
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref20
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref20
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref20
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref21
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref21
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref21
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref22
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref22
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref22
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref22
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref23
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref23
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref24
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref24
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref24
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref24
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref25
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref25
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref25
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref25
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref26
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref26
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref26
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref26
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref27
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref27
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref27
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref27
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref27
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref28
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref28
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref28
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref29
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref29
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref29
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref29
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref30
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref30
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref30
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref30
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref31
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref31
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref31
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref31
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref32
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref32
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref33
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref33
Human iPS Cell-Derived Neurons Uncover the Impact of Increased Ras
Signaling in Costello Syndrome. J. Neurosci. 36, 142–152.
Rosenfeld, J.A., Ballif, B.C., Torchia, B.S., Sahoo, T., Ravnan, J.B., Schultz, R.,
Lamb, A., Bejjani, B.A., and Shaffer, L.G. (2010). Copy number variations asso-
ciated with autism spectrum disorders contribute to a spectrum of neurodeve-
lopmental disorders. Genet. Med. 12, 694–702.
Russo, F.B., Cugola, F.R., Fernandes, I.R., Pignatari, G.C., and Beltr~ao-Braga,
P.C.B. (2015). Induced pluripotent stem cells for modeling neurological disor-
ders. World J. Transplant. 5, 209–221.
Shinawi, M., Liu, P., Kang, S.-H.L., Shen, J., Belmont, J.W., Scott, D.A.,
Probst, F.J., Craigen, W.J., Graham, B.H., Pursley, A., et al. (2010). Recurrent
reciprocal 16p11.2 rearrangements associated with global developmental
delay, behavioural problems, dysmorphism, epilepsy, and abnormal head
size. J. Med. Genet. 47, 332–341.
Simons Vip Consortium (2012). Simons Variation in Individuals Project (Simons
VIP): a genetics-first approach to studyingautism spectrum and related neuro-
developmental disorders. Neuron 73, 1063–1067.
Steinman, K.J., Spence, S.J., Ramocki, M.B., Proud, M.B., Kessler, S.K.,
Marco, E.J., Green Snyder, L., D’Angelo, D., Chen, Q., Chung, W.K., et al.
(2016). 16p11.2 deletion and duplication: Characterizing neurologic pheno-
types in a large clinically ascertained cohort. Am. J. Med. Genet. 170, 2943–
2955.
Tai, D.J.C., Ragavendran, A., Manavalan, P., Stortchevoi, A., Seabra, C.M.,
Erdin, S., Collins, R.L., Blumenthal, I., Chen, X., Shen, Y., et al. (2016). Engi-
neeringmicrodeletions andmicroduplications by targeting segmental duplica-
tions with CRISPR. Nat. Neurosci. 19, 517–522.
Turrigiano, G.G., and Nelson, S.B. (2004). Homeostatic plasticity in the devel-
oping nervous system. Nat. Rev. Neurosci. 5, 97–107.
Varga, E.A., Pastore, M., Prior, T., Herman, G.E., andMcBride, K.L. (2009). The
prevalence of PTEN mutations in a clinical pediatric cohort with autism spec-
trum disorders, developmental delay, and macrocephaly. Genet. Med. 11,
111–117.
Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T., Fossdal, R., Sae-
mundsen, E., Stefansson, H., Ferreira, M.A., Green, T., et al.; Autism Con-
sortium (2008). Association between microdeletion and microduplication at
16p11.2 and autism. N. Engl. J. Med. 358, 667–675.
Williams, M.R., DeSpenza, T., Jr., Li, M., Gulledge, A.T., and Luikart, B.W.
(2015). Hyperactivity of newborn Pten knock-out neurons results from
increased excitatory synaptic drive. J. Neurosci. 35, 943–959.
Yadav, S., Oses-Prieto, J.A., Peters, C.J., Zhou, J., Pleasure, S.J., Burlingame,
A.L., Jan, L.Y., and Jan, Y.-N. (2017). TAOK2 Kinase Mediates PSD95 Stability
and Dendritic Spine Maturation through Septin7 Phosphorylation. Neuron 93,
379–393.
Yu, Z., Fotouhi-Ardakani, N., Wu, L., Maoui, M., Wang, S., Banville, D., and
Shen, S.-H. (2002). PTEN associates with the vault particles in HeLa cells.
J. Biol. Chem. 277, 40247–40252.
Zhang, S.-C., Wernig, M., Duncan, I.D., Br€ustle, O., and Thomson, J.A. (2001).
In vitro differentiation of transplantable neural precursors from human embry-
onic stem cells. Nat. Biotechnol. 19, 1129–1133.
Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell,
C.M., and Parada, L.F. (2009). Pharmacological inhibition of mTORC1 sup-
presses anatomical, cellular, and behavioral abnormalities in neural-specific
Pten knock-out mice. J. Neurosci. 29, 1773–1783.
Cell Reports 21, 2678–2687, December 5, 2017 2687
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref33
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref33
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref34
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref34
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref34
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref34
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref35
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref35
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref35
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref35
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref36
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref36
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref36
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref36
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref36
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref37
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref37
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref37
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref38
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref38
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref38
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref38
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref38
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref39
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref39
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref39
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref39
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref40
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref40
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref41
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref41
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref41
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref41
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref42
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref42
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref42
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref42
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref43
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref43
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref43
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref44
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref44
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref44
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref44
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref45
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref45
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref45
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref46
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref46
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref46
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref46
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref47
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref47
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref47
http://refhub.elsevier.com/S2211-1247(17)31674-1/sref47
	Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder
	Introduction
	Results
	Generation of iPSCs from 16p11.2 CNV Carriers and Differentiation into NPCs
	16p11.2 CNV Carrier-Derived Neurons Show Altered Morphometric Characteristics
	Intrinsic Excitability of 16pdel Carrier-Derived Neurons Corroborates the Cell Size Phenotype
	Altered Synaptic Development in 16p11.2 CNV Carrier-Derived Neurons
	Discussion
	Experimental Procedures
	16p11.2 CNV Carriers
	Generation of iPSCs Using Episomal Vectors
	Characterization of iPSCs from 16p11.2 CNV Carriers
	Statistical Analyses
	Supplemental Information
	Author Contributions
	Acknowledgments
	References

Mais conteúdos dessa disciplina